MG Partners closes €80M healthcare fund, gains €200M firepower for Benelux buy-and-build
What's the deal? Dutch private equity firm MG PartnersDealroom has a profile for this one. Try Dealroom → has reached the final close of MG Invest VII Coöperatie, an €80m ($91m) fund targeting healthcare companies across the Benelux. The firm also secured a dedicated debt facility from a European direct lending partner, bringing its total investment capacity to about €200m.
What's the endgame? MG Invest VII pursues a buy-and-build strategy in fragmented healthcare markets. It backs entrepreneurial management teams that can deliver more accessible, affordable, and higher-quality care.
Why now? The fund reached its hard cap after an oversubscribed process and includes a substantial GP commitment. MG Partners frames healthcare as one of Europe's most attractive long-term sectors, citing structural demand, demographic trends, and increasing specialisation.
“The strong support for MG Invest VII reflects the trust we have built over many years,” said partner Marvin de Jong. He added that the firm will deploy the capital by “partnering with entrepreneurial healthcare providers that are committed to delivering high-quality, accessible care across the Benelux.”
MG Partners positions itself as an active partner, providing capital, operational expertise, and access to its healthcare network in the region. Its portfolio includes Nederlandse Klinieken Groep, backed since 2022.
The signal: With practitioners scarce and demand rising, consolidating fragmented healthcare providers remains a favoured private equity play. “Ultimately leading to more accessible, affordable and higher quality care,” said managing partner René ManchesterDealroom has a profile for this one. Try Dealroom →.
Read more: Investors in Healthcare
Image credit: Massachusetts Dept. of Environmental Protection
